The introduction of the Retatru vial signifies a notable shift in the landscape to weight regulation. This novel therapy combines two distinct mechanisms – agonist of the GLP-1 receptor and reduction of the DPP-4 enzyme – offering a different strategy for managing obesity . Early patient data suggest encouraging results in promoting meaningful … Read More